van Riel Pl
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Rheumatoid Arthritis Research and Therapies 5
- Systemic Lupus Erythematosus Research 2
- Spondyloarthritis Studies and Treatments 1
-
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- van de Putte Lb (6 shared papers)John Kirwan (2 shared papers)N. Khaltaev (1 shared paper)Muirden Kd (1 shared paper)Peter Tugwell (1 shared paper)Maarten Boers (1 shared paper)Smolen Js (1 shared paper)
- Journals
- PubMed (7 papers)
- Partner nations
- NetherlandsUnited KingdomJapan
In The Last Decade
van Riel Pl
7 papers receiving 323 citations
Peers
Comparison fields: 5 of 62
- Rheumatology 267
- Hematology 130
- Pathology and Forensic Medicine 70
- Genetics 25
- Complementary and Manual Therapy 4
Countries citing papers authored by van Riel Pl
This map shows the geographic impact of van Riel Pl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by van Riel Pl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites van Riel Pl more than expected).
Fields of papers citing papers by van Riel Pl
This network shows the impact of papers produced by van Riel Pl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by van Riel Pl. The network helps show where van Riel Pl may publish in the future.
Co-authors
The 7 scholars most cited alongside van Riel Pl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. | 1994 | 229 |
| 2 | Validity of single variables and indices to measure disease activity in rheumatoid arthritis. | 1993 | 71 |
| 3 | Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities. | 1983 | 23 |
| 4 | Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination. | 1983 | 6 |
| 5 | DC-ART: what proportion of response constitutes a positive response? | 1994 | 5 |
| 6 | DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage. | 1994 | 5 |
| 7 | [Rheumajecta and Vasolastine treatment of primary fibromyalgia; results of a randomized placebo-controlled double-blind study]. | 1990 | 4 |
About van Riel Pl
van Riel Pl is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging, Hematology, Anatomy and Immunology and Allergy, having authored 7 papers that have together received 343 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (5 papers), Systemic Lupus Erythematosus Research (2 papers), Spondyloarthritis Studies and Treatments (1 paper), Bone and Joint Diseases (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Cell Adhesion Molecules Research (1 paper), Medical and Biological Sciences (1 paper) and Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper). The work is most often cited by research in Rheumatology (267 citations), Hematology (130 citations), Pathology and Forensic Medicine (70 citations), Genetics (25 citations) and Complementary and Manual Therapy (4 citations) van Riel Pl has collaborated with scholars based in Netherlands, United Kingdom and Japan. Frequent co-authors include van de Putte Lb, John Kirwan, N. Khaltaev, Muirden Kd, Peter Tugwell, Maarten Boers and Smolen Js. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.